Skip to content

A Phase 4 Pragmatic, Randomized Trial to Evaluate the Effectiveness and Safety of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19 (DAN-COVID)

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-523841-82-00
Acronym
DAN-COVID
Enrollment
275000
Registered
2025-11-26
Start date
2025-12-11
Completion date
Unknown
Last updated
2025-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

SARS-CoV-2 infection

Brief summary

Medically attended COVID-19, defined as a positive PCR test for SARS-CoV-2 or hospitalization for COVID-19-related respiratory tract disease. The prespecified registry-based definition of the primary endpoint is as follows: Medically attended COVID-19 (ICD-10 codes: B342, B972, U071) diagnosis type: A. Requires either a positive SARS-CoV-2 PCR test from the Danish Microbiology Database OR COVID-19-related hospitalization

Detailed description

1. COVID-19-related hospitalization, 2. COVID-19-related respiratory tract disease hospitalization, 3. COVID-19-related cardio-respiratory disease hospitalization, 4. All-cause respiratory tract infection hospitalization, 5. All-cause cardio-respiratory hospitalization, 6. All-cause lower respiratory tract disease hospitalization, 7. All-cause hospitalization, 8. COVID-19 death, 9. All-cause death

Interventions

Sponsors

Gentofte Hospital, Moderna Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Medically attended COVID-19, defined as a positive PCR test for SARS-CoV-2 or hospitalization for COVID-19-related respiratory tract disease. The prespecified registry-based definition of the primary endpoint is as follows: Medically attended COVID-19 (ICD-10 codes: B342, B972, U071) diagnosis type: A. Requires either a positive SARS-CoV-2 PCR test from the Danish Microbiology Database OR COVID-19-related hospitalization

Secondary

MeasureTime frame
1. COVID-19-related hospitalization, 2. COVID-19-related respiratory tract disease hospitalization, 3. COVID-19-related cardio-respiratory disease hospitalization, 4. All-cause respiratory tract infection hospitalization, 5. All-cause cardio-respiratory hospitalization, 6. All-cause lower respiratory tract disease hospitalization, 7. All-cause hospitalization, 8. COVID-19 death, 9. All-cause death

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026